Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)
Clinical trial NCT06280482 · RECRUITING
Trial details
- NCT number
- NCT06280482
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-06
- Primary completion
- 2027-07-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.